AU2003235749A1 - Biomarkers for detecting ovarian cancer - Google Patents

Biomarkers for detecting ovarian cancer

Info

Publication number
AU2003235749A1
AU2003235749A1 AU2003235749A AU2003235749A AU2003235749A1 AU 2003235749 A1 AU2003235749 A1 AU 2003235749A1 AU 2003235749 A AU2003235749 A AU 2003235749A AU 2003235749 A AU2003235749 A AU 2003235749A AU 2003235749 A1 AU2003235749 A1 AU 2003235749A1
Authority
AU
Australia
Prior art keywords
biomarkers
ovarian cancer
detecting ovarian
detecting
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003235749A
Other versions
AU2003235749A8 (en
Inventor
Daniel W. Chan
Alex Jaideep Rai
Zhen Zheng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johns Hopkins University
Original Assignee
Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johns Hopkins University filed Critical Johns Hopkins University
Publication of AU2003235749A1 publication Critical patent/AU2003235749A1/en
Publication of AU2003235749A8 publication Critical patent/AU2003235749A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57449—Specifically defined cancers of ovaries
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/44—Antibodies bound to carriers
AU2003235749A 2002-01-07 2003-01-07 Biomarkers for detecting ovarian cancer Abandoned AU2003235749A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34653602P 2002-01-07 2002-01-07
US60/346,536 2002-01-07
PCT/US2003/000531 WO2003057014A2 (en) 2002-01-07 2003-01-07 Biomarkers for detecting ovarian cancer

Publications (2)

Publication Number Publication Date
AU2003235749A1 true AU2003235749A1 (en) 2003-07-24
AU2003235749A8 AU2003235749A8 (en) 2003-07-24

Family

ID=23359856

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003235749A Abandoned AU2003235749A1 (en) 2002-01-07 2003-01-07 Biomarkers for detecting ovarian cancer

Country Status (2)

Country Link
AU (1) AU2003235749A1 (en)
WO (1) WO2003057014A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2493817A1 (en) 2002-08-06 2004-02-12 The John Hopkins University Use of biomarkers for detecting ovarian cancer
US7425700B2 (en) 2003-05-22 2008-09-16 Stults John T Systems and methods for discovery and analysis of markers
EA200600346A1 (en) * 2003-08-01 2006-08-25 Коррелоджик Системз, Инк. MULTIPLE PROTOMIC PROPERTIES OF SERUM OBTAINED BY HIGH RESOLUTION SPECTROMETRY FOR OVARIAN CANCER
CA2537955A1 (en) * 2003-09-05 2005-03-17 Royal Women's Hospital Diagnostic marker for ovarian cancer
NZ560976A (en) * 2005-03-11 2011-06-30 Univ Johns Hopkins Biomarkers for ovarian cancer and endometrial cancer: hepcidin
WO2007002535A2 (en) * 2005-06-24 2007-01-04 Ciphergen Biosystems, Inc. Biomarkers for ovarian cancer
AU2015210343B2 (en) * 2005-06-24 2017-09-28 Aspira Women’s Health Inc. BIOMARKERS FOR OVARIAN CANCER: ß-2 MICROGLOBULIN
AU2012216473B2 (en) * 2005-06-24 2015-08-20 Aspira Women’s Health Inc. Biomarkers for ovarian cancer: beta-2 microglobulin
US7910318B2 (en) 2005-09-15 2011-03-22 The Royal Institution For The Advancement Of Learning/Mcgill University Methods of diagnosing ovarian cancer and kits therefor
US7491504B2 (en) * 2005-11-22 2009-02-17 Frantz Biomarkers, Llc Method for detecting ovarian cancer
US20080020472A1 (en) * 2005-11-22 2008-01-24 Frantz Biomarkers, Llc Method for detecting an inflammatory disease or cancer
EP2220506B1 (en) 2007-10-29 2013-10-02 Vermillion, Inc. Biomarkers for the detection of early stage ovarian cancer
US8962257B2 (en) 2010-03-08 2015-02-24 The Trustees Of The University Of Pennsylvania Methods for diagnosing heart failure and other cardiac diseases
WO2012120377A2 (en) 2011-03-08 2012-09-13 King Abdullah University Of Science And Technology Molecular biomarker set for early detection of ovarian cancer
DK2683419T3 (en) 2011-03-11 2018-07-02 Vib Vzw Molecules and Methods for Inhibition and Detection of Proteins
US11761959B2 (en) 2013-03-15 2023-09-19 The Trustees Of The University Of Pennsylvania Blood biomarker that predicts persistent cognitive dysfunction after concussion
WO2021026172A1 (en) 2019-08-05 2021-02-11 Seer, Inc. Systems and methods for sample preparation, data generation, and protein corona analysis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6031090A (en) * 1989-07-31 1991-03-11 University Of British Columbia, The Monoclonal antibodies against a tumor-associated antigen
WO2001033228A2 (en) * 1999-11-03 2001-05-10 Oncotech, Inc. Cancer diagnosis employing cell-sorting and gene-profiles

Also Published As

Publication number Publication date
AU2003235749A8 (en) 2003-07-24
WO2003057014A2 (en) 2003-07-17
WO2003057014A3 (en) 2004-05-13
WO2003057014A9 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
EP1756566A4 (en) Biomarkers for ovarian cancer
AU2003294205A1 (en) Prostate cancer biomarkers
EP1654526A4 (en) Biomarker panel for colorectal cancer
EP1697497A4 (en) Liver cancer biomarkers
IL173471A0 (en) Multiple high-resolution serum proteomic features for ovarian cancer detection
IL185496A0 (en) Biomarkers for ovarian cancer and endometrial cancer: hepcidin
AU2003235749A1 (en) Biomarkers for detecting ovarian cancer
AU2009210417A1 (en) Method of detecting thyroid cancer
AU2003244122A1 (en) Biomolecule analyzer
AU2003294828A1 (en) Specific markers for pancreatic cancer
AU2003213960A1 (en) Methods for detecting ovarian cancer
AU2003269618A1 (en) Methods for detecting breast and ovarian cancer
AU2003271456A1 (en) Methods for detecting endocrine cancer
AU2003273007A1 (en) Test strip for creatinine determination
AU2003231084A1 (en) Identification of biomarkers for detecting prostate cancer
AU2003274314A1 (en) Detecting apparatus
AU2003264488A1 (en) Immunotherapeutic for cancer
EP1952143A4 (en) Method for detecting ovarian cancer
AU2003272964A1 (en) Remedy for hormone-dependent cancer
EP1644530A4 (en) Methylated gene biomarkers for detecting cancer
EP1672081A4 (en) Primer for detecting alicyclobacillus
AU2003270351A1 (en) Anesthetic-state determining
AU2003287564A1 (en) Methods of detecting colorectal cancer
AU2003302018A1 (en) Methods of detecting ovarian neoplasia
AU2003288653A1 (en) Arrangement for determining position

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase